Abstract:The application of Artificial Intelligence (AI) to screen drug molecules with potential therapeutic effects has revolutionized the drug discovery process, with significantly lower economic cost and time consumption than the traditional drug discovery pipeline. With the great power of AI, it is possible to rapidly search the vast chemical space for potential drug-target interactions (DTIs) between candidate drug molecules and disease protein targets. However, only a small proportion of molecules have labelled DTIs, consequently limiting the performance of AI-based drug screening. To solve this problem, a machine learning-based approach with great ability to generalize DTI prediction across molecules is desirable. Many existing machine learning approaches for DTI identification failed to exploit the full information with respect to the topological structures of candidate molecules. To develop a better approach for DTI prediction, we propose GraphormerDTI, which employs the powerful Graph Transformer neural network to model molecular structures. GraphormerDTI embeds molecular graphs into vector-format representations through iterative Transformer-based message passing, which encodes molecules' structural characteristics by node centrality encoding, node spatial encoding and edge encoding. With a strong structural inductive bias, the proposed GraphormerDTI approach can effectively infer informative representations for out-of-sample molecules and as such, it is capable of predicting DTIs across molecules with an exceptional performance. GraphormerDTI integrates the Graph Transformer neural network with a 1-dimensional Convolutional Neural Network (1D-CNN) to extract the drugs' and target proteins' representations and leverages an attention mechanism to model the interactions between them. To examine GraphormerDTI's performance for DTI prediction, we conduct experiments on three benchmark datasets, where GraphormerDTI achieves a superior performance than five state-of-the-art baselines for out-of-molecule DTI prediction, including GNN-CPI, GNN-PT, DeepEmbedding-DTI, MolTrans and HyperAttentionDTI, and is on a par with the best baseline for transductive DTI prediction. The source codes and datasets are publicly accessible at https://github.com/mengmeng34/GraphormerDTI .

GTransCYPs: an improved graph transformer neural network with attention pooling for reliably predicting CYP450 inhibitors

BiTGNN: Prediction of drug–target interactions based on bidirectional transformer and graph neural network on heterogeneous graph

Predicting drug–protein interactions by preserving the graph information of multi source data

Gtie-Rt: A comprehensive graph learning model for predicting drugs targeting metabolic pathways in human

GraphormerDTI: A graph transformer-based approach for drug-target interaction prediction

Prediction of human cytochrome P450 inhibition using a multi-task deep autoencoder neural network.

MTrans: M-Transformer and Knowledge Graph-Based Network for Predicting Drug–Drug Interactions

GraphsformerCPI: Graph Transformer for Compound–Protein Interaction Prediction

Unlocking the therapeutic potential of drug combinations through synergy prediction using graph transformer networks

SMGCN: Multiple Similarity and Multiple Kernel Fusion Based Graph Convolutional Neural Network for Drug-Target Interactions Prediction.

Towards a Better Model with Dual Transformer for Drug Response Prediction

Prediction of Cytochrome P450 Inhibition Using a Deep Learning Approach and Substructure Pattern Recognition

GCMCDTI: Graph Convolutional Autoencoder Framework for Predicting Drug-Target Interactions Based on Matrix Completion.

An Edge-based Graph Transformer Network for Anti-Cancer Drug Synergy Prediction

Predicting Drug-target Binding Affinity Based on Graph Isomorphism Network and iTransformer

Development of In Silico Models for Predicting Potential Time-Dependent Inhibitors of Cytochrome P450 3A4

In silico prediction of UGT-mediated metabolism in drug-like molecules via graph neural network

TransCDR: a deep learning model for enhancing the generalizability of cancer drug response prediction through transfer learning and multimodal data fusion for drug representation

Harnessing machine learning to predict cytochrome P450 inhibition through molecular properties

Graph Convolutional Autoencoder and Generative Adversarial Network-Based Method for Predicting Drug-Target Interactions

DeepP450: Predicting Human P450 Activities of Small Molecules by Integrating Pretrained Protein Language Model and Molecular Representation